81 related articles for article (PubMed ID: 1746204)
21. The development of over-the-counter (OTC) assays for pregnanediol-3-glucuronide and estrone-B,D-glucuronide.
Bahar I
Prog Clin Biol Res; 1988; 285():139-51. PubMed ID: 3231643
[TBL] [Abstract][Full Text] [Related]
22. [Qualitative determination of U-pregnanediol-3 alpha-glucuronide in 5 minutes. A clinical trial of a new matrix cushion test].
Bødker B; Philipsen T; Bagger PV
Ugeskr Laeger; 1990 Apr; 152(18):1307-8. PubMed ID: 2188406
[TBL] [Abstract][Full Text] [Related]
23. Ovarian function immediately after the menarche.
Borsos A; Lampé LG; Balogh A; Csoknyay J; Ditroi F
Int J Gynaecol Obstet; 1986 Jun; 24(3):239-42. PubMed ID: 2880764
[TBL] [Abstract][Full Text] [Related]
24. Menstrual cycle, trait estrogen level, and masculinity preferences in the human voice.
Feinberg DR; Jones BC; Law Smith MJ; Moore FR; DeBruine LM; Cornwell RE; Hillier SG; Perrett DI
Horm Behav; 2006 Feb; 49(2):215-22. PubMed ID: 16055126
[TBL] [Abstract][Full Text] [Related]
25. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function.
Magini A; Pinzani P; Bolelli GF; Bassi F; Salerno R; Messeri G; Pazzagli M
J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241
[TBL] [Abstract][Full Text] [Related]
26. Monitoring induction of ovulation by rapid radioimmunoassays of oestrogen and pregnanediol glucuronides.
MacLean AR; Outch KH; Russell JM; Brown JB; Dennis PM
Ann Clin Biochem; 1981 Nov; 18(Pt 6):343-9. PubMed ID: 7316453
[TBL] [Abstract][Full Text] [Related]
27. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
28. Hormonal monitoring of ovarian activity using the Ovarian Monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay.
Blackwell LF; Brown JB; Vigil P; Gross B; Sufi S; d'Arcangues C
Steroids; 2003 May; 68(5):465-76. PubMed ID: 12798498
[TBL] [Abstract][Full Text] [Related]
29. Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle.
Blackwell LF; Brown JB; Cooke D
Steroids; 1998 Jan; 63(1):5-13. PubMed ID: 9437789
[TBL] [Abstract][Full Text] [Related]
30. Induction of ovulation with human pituitary gonadotrophin. Twelve years' experience.
Kovacs GT; Dennis PM; Shelton RJ; Outch KH; McLean RA; Healy DL; Burger HG
Med J Aust; 1984 May; 140(10):575-9. PubMed ID: 6717330
[TBL] [Abstract][Full Text] [Related]
31. The effect of the menstrual cycle on exhaled nitric oxide and urinary nitrate concentration.
Morris NH; Sooranna SR; Steer PJ; Warren JB
Eur J Clin Invest; 1996 Jun; 26(6):481-4. PubMed ID: 8817162
[TBL] [Abstract][Full Text] [Related]
32. Sulpiride and the potentiation of progestogen only contraception.
Payne MR; Howie PW; McNeilly AS; Cooper W; Marnie M; Kidd L
Br Med J (Clin Res Ed); 1985 Aug; 291(6495):559-61. PubMed ID: 2994800
[TBL] [Abstract][Full Text] [Related]
33. [Comparative study of urinary pregnanediol and endometrial biopsy as ovulation parameters].
Garciá Flores RF; Merino de García M
Ginecol Obstet Mex; 1982 Sep; 50(305):249-51. PubMed ID: 7186864
[No Abstract] [Full Text] [Related]
34. Validations of time-resolved fluoroimmunoassays for urinary estrone 3-glucuronide and pregnanediol 3-glucuronide.
Kesner JS; Knecht EA; Krieg EF; Barnard G; Mikola HJ; Kohen F; Gani MM; Coley J
Steroids; 1994 Mar; 59(3):205-11. PubMed ID: 8048153
[TBL] [Abstract][Full Text] [Related]
35. The validation of the Billings ovulation method by laboratory research and field trials.
Billings JJ
Acta Eur Fertil; 1991; 22(1):9-15. PubMed ID: 1746210
[TBL] [Abstract][Full Text] [Related]
36. Determination of ovarian function using first morning urine steroid assays.
Denari JH; Farinati Z; Casas PR; Oliva A
Obstet Gynecol; 1981 Jul; 58(1):5-9. PubMed ID: 7195531
[TBL] [Abstract][Full Text] [Related]
37. Urinary progesterone and pregnanediol. Use for monitoring progesterone treatment.
Stanczyk FZ; Gentzschein E; Ary BA; Kojima T; Ziogas A; Lobo RA
J Reprod Med; 1997 Apr; 42(4):216-22. PubMed ID: 9131494
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein across the menstrual cycle.
Wander K; Brindle E; O'Connor KA
Am J Phys Anthropol; 2008 Jun; 136(2):138-46. PubMed ID: 18257023
[TBL] [Abstract][Full Text] [Related]
39. Rapid immunochemical assay of pregnanediol-3-glucuronide in urine and its clinical application.
Hiroi M; Kawagoe S; Saito H; Saito N; Kubota N; Tsubota N
Gynecol Obstet Invest; 1986; 22(4):186-93. PubMed ID: 3817603
[TBL] [Abstract][Full Text] [Related]
40. Pregnancy hormone metabolite patterns, pregnancy symptoms, and coffee consumption.
Lawson CC; LeMasters GK; Levin LS; Liu JH
Am J Epidemiol; 2002 Sep; 156(5):428-37. PubMed ID: 12196312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
